Drug class
Hematopoietic Stem Cell Mobilizer; Increased Hematopoietic Stem Cell Mobilization
Mechanism of action
Plerixafor is an inhibitor of the CXCR4 chemokine receptor and blocks binding of its cognate ligand, stromal cell-derived factor-1α (SDF-1α).
General use cases
- Lymphoma, Non-Hodgkin
- Multiple Myeloma
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
